Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design (Q34011677)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Randomized, double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder: novel findings using a simulated adult workplace environment design (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

0 references

attention deficit hyperactivity disorder

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1

object named as

Timothy Wigal

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

object named as

Matthew Brams

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Maria Gasior

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Joseph Gao

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Liza Squires

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

John Giblin

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

316 Study Group

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

24 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Behavioral and Brain Functions

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Absorption of lisdexamfetamine dimesylate and its enzymatic conversion to d-amphetamine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

A 13-hour laboratory school study of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Cross-national prevalence and correlates of adult attention-deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Does OROS-methylphenidate improve core symptoms and deficits in executive function? Results of an open-label trial in adults with attention deficit hyperactivity disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

A clinical perspective of attention-deficit/hyperactivity disorder into adulthood

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Attention-deficit/hyperactivity disorder in adults: a survey of current practice in psychiatry and primary care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Diagnosis and evaluation of adults with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

A comparison of once-daily extended-release methylphenidate formulations in children with attention-deficit/hyperactivity disorder in the laboratory school (the Comacs Study).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Development of a new once-a-day formulation of methylphenidate for the treatment of attention-deficit/hyperactivity disorder: proof-of-concept and proof-of-product studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

Pharmacotherapy of Adult Attention Deficit/Hyperactivity Disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

5 July 2018

A simulated workplace experience for nonmedicated adults with and without ADHD.

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Lisdexamfetamine dimesylate: the first long-acting prodrug stimulant treatment for attention deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

The laboratory school protocol: its origin, use, and new applications.

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Analog classroom assessment of a once-daily mixed amphetamine formulation, SLI381 (Adderall XR), in children with ADHD.

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

A randomized, double-blind, crossover study of once-daily dexmethylphenidate in children with attention-deficit hyperactivity disorder: rapid onset of effect

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Efficacy and duration of effect of extended-release dexmethylphenidate versus placebo in schoolchildren with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

A randomized, placebo-controlled trial of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1186%2F1744-9081-6-34

21 January 2018

Double-blind, placebo-controlled study of the efficacy and safety of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

29 October 2018

Triple-bead mixed amphetamine salts (SPD465), a novel, enhanced extended-release amphetamine formulation for the treatment of adults with ADHD: a randomized, double-blind, multicenter, placebo-controlled study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

29 October 2018

Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

29 October 2018

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2908054

29 October 2018

Functional impairments in adults with self-reports of diagnosed ADHD: A controlled study of 1001 adults in the community

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20576091

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1744-9081-6-34

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

release_j2ugg2xzbvhg7b4jam7ttxeb2q

1 reference

https://api.fatcat.wiki/v0/release/j2ugg2xzbvhg7b4jam7ttxeb2q

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34011677&oldid=2196112181"